Among the 39 patients with T-cell ALL, the frequency increases to 30.7% and 23.1%, for TRA/D(14) (q11.2) and CDKN2A del(9)(p21), respectively. This evidence concerns the gene CDKN2A and T-cell acute lymphoblastic leukemia.